| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/12/1994 | EP0577646A1 Sustained release drug delivery devices |
| 01/11/1994 | US5278332 Ethers of myoinsitol phosphate for drugs or foods |
| 01/11/1994 | US5277907 Regulation of the immune system |
| 01/11/1994 | CA1325973C Cyclosporin-containing pharmaceutical composition |
| 01/06/1994 | WO1994000486A1 Neuropeptide y antagonists |
| 01/06/1994 | WO1994000453A1 Purinone antianginal agents |
| 01/06/1994 | WO1994000160A1 Ophthalmic compositions and methods for preserving and using same |
| 01/06/1994 | WO1994000120A1 Chemical compounds |
| 01/06/1994 | WO1994000095A2 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 01/06/1994 | WO1993016701A3 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
| 01/06/1994 | CA2138374A1 Neuropeptide y antagonists |
| 01/06/1994 | CA2138124A1 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 01/05/1994 | CN1080188A Prevention of retinal injury and degeneration by specific factors |
| 01/04/1994 | US5276048 4-(1H-pyrrol-1-yl)imidazoles with angiotensin II antagonist activity |
| 01/04/1994 | CA1325811C Norbornane derivatives, process for their preparation, and cosmetic and pharmaceutical compositions containing them |
| 12/29/1993 | EP0576357A1 Pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 12/29/1993 | EP0575524A1 Method and products for treating the eye |
| 12/29/1993 | EP0575494A1 Leukotriene antagonists |
| 12/29/1993 | EP0575454A1 Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof. |
| 12/28/1993 | US5274104 N-substituted heterocyclic derivatives useful in the treatment of cardiovascular disorders |
| 12/23/1993 | WO1993026053A1 Micromechanical thermoelectric sensor element |
| 12/23/1993 | WO1993025530A2 Vinyl arenas having retinoid-like activity |
| 12/23/1993 | WO1993025199A1 Alpha-2-adrenergic agonists for treating presbyopia |
| 12/23/1993 | DE4219782A1 New benzimidazol-1-yl-methyl-bi:phenyl derivs. |
| 12/23/1993 | CA2137819A1 Vinyl arenas having retinoid-like activity |
| 12/23/1993 | CA2137285A1 Alpha-2-adrenergic agonists for treating presbyopia |
| 12/22/1993 | CN1079649A Imidazolyl-alkenoic acids |
| 12/22/1993 | CN1079648A Imidazolyl-alkenoic acids |
| 12/21/1993 | US5272147 Pyrazolopyrimidinone antianginal agents |
| 12/21/1993 | CA1325382C Locally administrable therapeutic composition for inflammatory disease |
| 12/15/1993 | EP0574174A2 Angiotensin II antagonists |
| 12/15/1993 | EP0573777A1 Oral pharmaceutical compositions containing anthocyanosides |
| 12/15/1993 | CN1079464A New compounds |
| 12/14/1993 | US5270342 Acetamide derivatives |
| 12/14/1993 | US5270051 Enzyme-orthokeratology |
| 12/14/1993 | US5270050 Paracetamol-based pharmaceutical composition |
| 12/14/1993 | US5270049 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives |
| 12/09/1993 | WO1993024529A1 Retinal pigmented epithelium derived neurotrophic factor |
| 12/09/1993 | WO1993024477A1 Chromone derivative and aldose reductase inhibitor containing the same as active ingredient |
| 12/09/1993 | WO1993024473A1 7-(2-aminoethyl)-benzothiazolones |
| 12/09/1993 | WO1993024466A1 Novel pilocarpine derivatives and process for their preparation |
| 12/09/1993 | WO1993024142A1 New pharmaceutical uses of krill enzymes |
| 12/09/1993 | WO1993024134A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1 |
| 12/09/1993 | WO1993024121A1 Remedy for glaucoma |
| 12/09/1993 | WO1993014750A3 Amino acids useful as inhibitors of the advanced glycosylation of proteins |
| 12/09/1993 | CA2306952A1 Method for removing dental plaque |
| 12/09/1993 | CA2136349A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1 |
| 12/09/1993 | CA2136321A1 Pharmaceutical composition for use in glaucoma treatment |
| 12/08/1993 | EP0573271A1 Angiotensin II antagonists |
| 12/08/1993 | EP0572560A1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
| 12/08/1993 | EP0572455A1 Substituted pyridinones and pyrimidinones as angiotensin ii antagonists |
| 12/07/1993 | US5268375 Dinitrogen heterocyclic derivatives N-substituted by a biphenylmethyl group, and the pharmaceutical compositions in which they are present |
| 12/04/1993 | CA2097462A1 Angiotensin ii antagonists |
| 12/04/1993 | CA2097460A1 Angiotensin ii antagonists |
| 12/01/1993 | EP0572190A1 Ophthalmic compositions containing vitamin E or ester thereof as an active ingredient |
| 12/01/1993 | EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 11/27/1993 | CA2096902A1 Ophthalmic compositions containing vitamin e or ester thereof as an active ingredient |
| 11/25/1993 | WO1993023399A1 6-AMINO SUBSTITUTED IMIDAZO[4,5-b]PYRIDINES AS ANGIOTENSIN II ANTAGONISTS |
| 11/25/1993 | WO1993023397A1 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors |
| 11/25/1993 | WO1993023395A1 Heteroaromatic quinuclidinenes, their use and preparation |
| 11/25/1993 | WO1993023082A1 Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents |
| 11/25/1993 | WO1993023010A1 Ophthalmic compositions containing a cyclosporin |
| 11/25/1993 | CA2135188A1 6-amino substituted imidazo(4,5-b)pyridines as angiotensin ii antagonists |
| 11/25/1993 | CA2131101A1 Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents |
| 11/23/1993 | US5264578 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 11/23/1993 | US5264449 N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol-5-yl)methyl]-2-pyrrolidinone |
| 11/16/1993 | CA1324374C 17-halomethylene estratrienes |
| 11/11/1993 | WO1993021936A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 11/11/1993 | WO1993021903A1 Use of borate-polyol complexes in ophthalmic compositions |
| 11/11/1993 | WO1993021894A2 Treatment of macular degeneration |
| 11/10/1993 | EP0569046A1 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 11/09/1993 | US5260329 Angiogenesis inhibitors |
| 11/09/1993 | US5260314 Certain 3-(1,2,5-oxa- or thiadiazol-4-yl)-1-azabicyclo [2.2.2]octanes having pharmaceutical properties |
| 11/03/1993 | EP0568306A1 Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| 11/03/1993 | EP0568289A2 Benzothiophenes and thienothiophenes and related compounds useful, for example, as urokinase inhibitors |
| 11/03/1993 | EP0567816A1 Use of inhibitors of plasminogen activators for treating of inflammations and wounds |
| 11/03/1993 | CN1077953A 乙酸衍生物 Acetic acid derivatives |
| 11/02/1993 | US5258374 Administering furosemide |
| 11/02/1993 | US5258183 Medicine based on neutralized sulphur derivatives |
| 11/02/1993 | CA2094332A1 Urokinase inhibitors |
| 10/31/1993 | CA2095207A1 Use of inhibitors of plasminogen activators for the treatment of inflammations and wounds |
| 10/28/1993 | WO1993021215A1 Peptides having tachykinin antagonist activity |
| 10/28/1993 | WO1993021172A1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 10/28/1993 | WO1993020823A1 Ocular androgen therapy in sjögren's syndrome |
| 10/28/1993 | WO1993020805A1 Chemical prevention or reversal of cataract by phase separation inhibitors |
| 10/28/1993 | WO1993020696A1 Regulation of the immune system |
| 10/28/1993 | WO1993018762A3 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists |
| 10/28/1993 | WO1993016719A3 Use of platelet derived growth factor in ophthalmic wound healing |
| 10/28/1993 | CA2133727A1 Chemical prevention or reversal of cataract by phase separation inhibitors |
| 10/28/1993 | CA2118503A1 Peptides having tachykinin antagonist activity |
| 10/27/1993 | EP0567431A1 Apparatus for removing components from solutions |
| 10/26/1993 | US5256698 Treatment of psychosis using cyclohexyl-phenyl-lower alkyl amine derivatives |
| 10/26/1993 | US5256671 A prodrug as tachykinin antagonists for treating headaches, pain or inflammation |
| 10/26/1993 | US5256667 Quinazolinones and pyridopyrimidinones |
| 10/26/1993 | CA2033975C Use of .beta.-receptor blocking agents |
| 10/25/1993 | CA2094665A1 Apparatus for removing components from solutions |
| 10/20/1993 | EP0566393A1 Stabilized solid pharmaceutical preparation and method of producing the same |
| 10/20/1993 | EP0566020A1 Benzimidazoles, pharmaceutical compositions thereof and processes for their preparation |
| 10/20/1993 | EP0565634A1 Angiotensin ii receptor blocking compositions |
| 10/20/1993 | EP0413692B1 Use of hexatriene derivatives for the manufacture of preparations for treating acne, psoriasis and light-induced damage to the skin |